This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Bachem Holding Ag. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Frank Dettner: Innovator in Peptide Purification
Introduction
Frank Dettner is a notable inventor based in Bubendorf, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the purification of peptide analogs. His work has implications for medical research and therapeutic applications.
Latest Patents
Dettner holds a patent for the "Purification of glucagon-like peptide 1 analogs." This invention refers to a method of purifying glucagon-like peptide 1 analogs through a two-dimensional reversed phase high-performance liquid chromatography protocol. The first step of this method is conducted at a pH value between 7.0 to 7.8, utilizing a mobile phase that includes a phosphate buffer and acetonitrile. The second step is performed at a pH value below 3.0, employing a mobile phase consisting of trifluoroacetic acid and acetonitrile. He has 1 patent to his name.
Career Highlights
Dettner is associated with Bachem Holding AG, a company renowned for its expertise in peptide synthesis and development. His role at Bachem has allowed him to contribute to advancements in peptide purification techniques, enhancing the quality and efficacy of peptide-based therapies.
Collaborations
Throughout his career, Dettner has collaborated with esteemed colleagues, including Andreas Stadelmaier and Ralph O Schoenleber. These partnerships have fostered innovation and have been instrumental in the development of new methodologies in peptide research.
Conclusion
Frank Dettner's work in the purification of glucagon-like peptide 1 analogs showcases his commitment to advancing biochemistry. His contributions are vital for the ongoing development of peptide-based therapies, and his collaborations further enhance the impact of his innovations.